What Can We Help You Find?

Latest In Research

The good news is that treatment options for lung cancer patients are rapidly improving. In the last two years, more treatments have been approved by the United States Food and Drug Administration (FDA) for the treatment of lung cancer than had been approved in the prior ten years. New and life saving treatments, along with clinical trials, are happening rapidly and LCFA is committed to keeping you up to date on the latest, most hopeful and helpful, information.

04/23
2020

Testing Patients with Lung Cancer for COVID-19

From Cancer Network In an article that will appear in Annals of Oncology, researchers outlined recommendations for testing patients with lung cancer for the coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by t…

04/16
2020

Conducting Clinical Trials During Coronavirus Pandemic

The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. Impact of Coronavirus on Clinical…

04/16
2020

Does Delaying ALK+ Treatment Impact Survival?

From the Journal Lung Cancer What effect does delaying ALK+ treatment have on survival? Several obstacles may result in delaying ALK+ treatment in patients with anaplastic lymphoma kinase positive (ALK+) non-small-cell lung cancer (N…

04/16
2020

Durvalumab Approved for SCLC

From Targeted Oncology The FDA has approved durvalumab (Imfinzi) in combination with standard-of-care chemotherapy, etoposide and carboplatin or cisplatin, as a frontline treatment for adult patients with extensive-stage small c…

03/31
2020

African American Lung Cancer Patients less likely to receive lung cancer imaging

From Medical Express African American Lung Cancer Patients and PET-CT imaging The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer (NSCLC), and this accurate imaging helps to match patients …

03/25
2020

Coronavirus and Cancer: 1-2 Punch

From Forbes You have cancer. Your treatment is difficult, laborious, expensive, and stressful- even on even the best of days. Now add coronavirus to the cancer equation. Enter, coronavirus. What now? This is the difficult questi…

03/25
2020

When Cancer And Coronavirus Collide

By MORHAF AL ACHKAR Cancer And Coronavirus: Fear And Resilience Dr. Morhaf Al Achkar, a lung cancer patient, shares his observations on the collision between cancer and coronavirus - a new world for all. It's like being in prison …

02/25
2020

Biomarker Testing and CT Screening Vital for Lung Cancer

From OncLive Biomarker Testing and CT Screening Advancements in the prevention and treatment of patients with lung cancer have picked up momentum over the past decade and now is the time to build on that progress according to Suresh …

02/5
2020

Faulty Immune System May Lead to Lung Cancer

From WebMD An immune system that's not functioning normally may lead to lung cancer in patients who don't smoke, a new study suggests. "A strong immune system helps to keep inflammation under control and chronic inflammation …

02/4
2020

Is Lung Cancer Related to Air Pollution?

From Dana Farber Cancer Center Pollution in the air was responsible for 223,000 lung cancer deaths worldwide in 2010, research shows.The findings prompted the World Health Organization to classify air pollution, for the first time, as a…

Research is imperative to improve treatment and management of all diseases and that’s particularly true of lung cancer. It’s creation of new knowledge, it’s discovery. It’s how we learn how to improve management of symptoms, to improve survival. ~Dr. David Johnson